2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Annette de Thurah; Philipp Bosch; Andrea Marques; Yvette Meissner; Chetan B. Mukhtyar; Johannes Knitza; Aurélie Najm; Nina Østerås; Tim Pelle; Line Raunsbæk Knudsen; Hana Šmucrová; Francis Berenbaum; Meghna Jani; Rinie Geenen; Martin Krusche; Polina Pchelnikova; Savia de Souza; Sara Badreh; Dieter Wiek; Silvia Piantoni; James M. Gwinnutt; Christina Duftner; Helena M. Canhão; Luca Quartuccio; Nikolay Stoilov; Yeliz Prior; Johannes W. J. Bijlsma; Alen Zabotti; Tanja A. Stamm; Christian Dejaco

doi:10.1136/annrheumdis-2022-222341

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Annette de Thurah, Philipp Bosch, Andrea Marques, Yvette Meissner, Chetan B. Mukhtyar, Johannes Knitza, Aurélie Najm, Nina Østerås, Tim Pelle, Line Raunsbæk Knudsen, Hana Šmucrová, Francis Berenbaum, Meghna Jani, Rinie Geenen, Martin Krusche, Polina Pchelnikova, Savia de Souza, Sara Badreh, Dieter Wiek, Silvia PiantoniJames M. Gwinnutt, Christina Duftner, Helena M. Canhão, Luca Quartuccio, Nikolay Stoilov, Yeliz Prior, Johannes W. J. Bijlsma, Alen Zabotti, Tanja A. Stamm, Christian Dejaco

Research output: Contribution to journal › Article › peer-review

65 Citations (Scopus)

8 Downloads (Pure)

Abstract

Background: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).

Objective: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.

Methods: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.

Results: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10.

Conclusion :The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

Original language	English
Pages (from-to)	1065-1071
Number of pages	7
Journal	Annals of the Rheumatic Diseases
Volume	81
Issue number	8
Early online date	24 Apr 2022
DOIs	https://doi.org/10.1136/annrheumdis-2022-222341
Publication status	Published - Aug 2022
Externally published	Yes

Keywords

Epidemiology
Health services research
Patient Care Team
FACE-TO-FACE
KNEE OSTEOARTHRITIS
EXERCISE MANAGEMENT
PHYSICAL-THERAPISTS
CONTROLLED-TRIAL
SERVICE MODELS
FOLLOW-UP
TELEPHONE
HEALTH
ARTHRITIS

Access to Document

10.1136/annrheumdis-2022-222341Licence: Unspecified

Ptc for remote care_revision_v2_clean_NO-tsAccepted author manuscript, 308 KBLicence: CC BY-NC

Cite this

de Thurah, A., Bosch, P., Marques, A., Meissner, Y., Mukhtyar, C. B., Knitza, J., Najm, A., Østerås, N., Pelle, T., Knudsen, L. R., Šmucrová, H., Berenbaum, F., Jani, M., Geenen, R., Krusche, M., Pchelnikova, P., de Souza, S., Badreh, S., Wiek, D., ... Dejaco, C. (2022). 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 81(8), 1065-1071. https://doi.org/10.1136/annrheumdis-2022-222341

@article{d48ae51c468b4662a47df841174b08fb,

title = "2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases",

abstract = "Background: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD). Objective: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD. Methods: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting. Results: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10. Conclusion :The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.",

keywords = "Epidemiology, Health services research, Patient Care Team, FACE-TO-FACE, KNEE OSTEOARTHRITIS, EXERCISE MANAGEMENT, PHYSICAL-THERAPISTS, CONTROLLED-TRIAL, SERVICE MODELS, FOLLOW-UP, TELEPHONE, HEALTH, ARTHRITIS",

author = "{de Thurah}, Annette and Philipp Bosch and Andrea Marques and Yvette Meissner and Mukhtyar, {Chetan B.} and Johannes Knitza and Aur{\'e}lie Najm and Nina {\O}ster{\aa}s and Tim Pelle and Knudsen, {Line Raunsb{\ae}k} and Hana {\v S}mucrov{\'a} and Francis Berenbaum and Meghna Jani and Rinie Geenen and Martin Krusche and Polina Pchelnikova and {de Souza}, Savia and Sara Badreh and Dieter Wiek and Silvia Piantoni and Gwinnutt, {James M.} and Christina Duftner and Canh{\~a}o, {Helena M.} and Luca Quartuccio and Nikolay Stoilov and Yeliz Prior and Bijlsma, {Johannes W. J.} and Alen Zabotti and Stamm, {Tanja A.} and Christian Dejaco",

note = "Funding Information: Funding MJ is funded by a National Institute for Health Research (NIHR) Advanced Fellowship [NIHR301413]. The project: {\textquoteright}Points to consider for remote care in rheumatic and musculoskeletal diseases (RMDs){\textquoteright} was funded by the European Alliance of Association for Rheumatology (EULAR). Project number CLI124 Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.",

year = "2022",

month = aug,

doi = "10.1136/annrheumdis-2022-222341",

language = "English",

volume = "81",

pages = "1065--1071",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "8",

}

de Thurah, A, Bosch, P, Marques, A, Meissner, Y, Mukhtyar, CB, Knitza, J, Najm, A, Østerås, N, Pelle, T, Knudsen, LR, Šmucrová, H, Berenbaum, F, Jani, M, Geenen, R, Krusche, M, Pchelnikova, P, de Souza, S, Badreh, S, Wiek, D, Piantoni, S, Gwinnutt, JM, Duftner, C, Canhão, HM, Quartuccio, L, Stoilov, N, Prior, Y, Bijlsma, JWJ, Zabotti, A, Stamm, TA & Dejaco, C 2022, '2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases', Annals of the Rheumatic Diseases, vol. 81, no. 8, pp. 1065-1071. https://doi.org/10.1136/annrheumdis-2022-222341

TY - JOUR

T1 - 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

AU - de Thurah, Annette

AU - Bosch, Philipp

AU - Marques, Andrea

AU - Meissner, Yvette

AU - Mukhtyar, Chetan B.

AU - Knitza, Johannes

AU - Najm, Aurélie

AU - Østerås, Nina

AU - Pelle, Tim

AU - Knudsen, Line Raunsbæk

AU - Šmucrová, Hana

AU - Berenbaum, Francis

AU - Jani, Meghna

AU - Geenen, Rinie

AU - Krusche, Martin

AU - Pchelnikova, Polina

AU - de Souza, Savia

AU - Badreh, Sara

AU - Wiek, Dieter

AU - Piantoni, Silvia

AU - Gwinnutt, James M.

AU - Duftner, Christina

AU - Canhão, Helena M.

AU - Quartuccio, Luca

AU - Stoilov, Nikolay

AU - Prior, Yeliz

AU - Bijlsma, Johannes W. J.

AU - Zabotti, Alen

AU - Stamm, Tanja A.

AU - Dejaco, Christian

N1 - Funding Information: Funding MJ is funded by a National Institute for Health Research (NIHR) Advanced Fellowship [NIHR301413]. The project: ’Points to consider for remote care in rheumatic and musculoskeletal diseases (RMDs)’ was funded by the European Alliance of Association for Rheumatology (EULAR). Project number CLI124 Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.

PY - 2022/8

Y1 - 2022/8

N2 - Background: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD). Objective: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD. Methods: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting. Results: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10. Conclusion :The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

AB - Background: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD). Objective: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD. Methods: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting. Results: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10. Conclusion :The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

KW - Epidemiology

KW - Health services research

KW - Patient Care Team

KW - FACE-TO-FACE

KW - KNEE OSTEOARTHRITIS

KW - EXERCISE MANAGEMENT

KW - PHYSICAL-THERAPISTS

KW - CONTROLLED-TRIAL

KW - SERVICE MODELS

KW - FOLLOW-UP

KW - TELEPHONE

KW - HEALTH

KW - ARTHRITIS

UR - http://www.scopus.com/inward/record.url?scp=85130828742&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2022-222341

DO - 10.1136/annrheumdis-2022-222341

M3 - Article

VL - 81

SP - 1065

EP - 1071

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 8

ER -

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Abstract

Keywords

Access to Document

Other files and links

Cite this